Agreement between different recall periods in drug utilization studies

Moraes, Cassia Garcia; Mengue, Sotero Serrate; Pizzol, Tatiane da Silva Dal.
Rev. bras. epidemiol ; 20(2): 324-334, Abr.-Jun. 2017. tab
Artigo em Inglês | LILACS | ID: biblio-898597

Documentos relacionados

  1. Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.
  2. Association between anticholinergic burden and anticholinergic adverse outcomes in the elderly: Pharmacological basis of their predictive value for adverse outcomes.
  3. Changes in Drug Utilization After Publication of Clinical Trials and Drug-Related Scandals in Japan: An Interrupted Time Series Analysis, 2005-2017.
  4. Unraveling the Mystery of Polyvalent Immunoglobulins in Belgium: Do We Have an Indication?
  5. Agreement between different recall periods in drug utilization studies.
  6. [Evaluation of drug utilization from positive lists].
  7. [An integrative review of drug utilization by the elderly in primary health care].
  8. Review shows substantial variations in the use of medication for infant bronchiolitis between and within countries.
  9. Interesting Properties of Profile Data Analysis in the Understanding and Utilization of the Effects of Drugs.
  10. Evaluation of the drug effect and rational use of antiseptic drugs in outpatient and emergency department of hospital.